Zai Lab Limited American Depositary Shares (ZLAB)

Price$17.09

Value ScoreC

Growth ScoreC

Momentum ScoreD

Favorite Metrics

Price vs S&P 500 (26W)-34.33%

Price vs S&P 500 (4W)-23.22%

VGM Score50.22

Market Capitalization$15.74B

All Metrics

Book Value / Share (Quarterly)$0.60

P/TBV (Annual)3.09x

Revenue Growth (3Y)28.86%

Cash Flow / Share (Quarterly)$-0.12

Price vs S&P 500 (YTD)-9.93%

Gross Margin (TTM)60.67%

Net Profit Margin (TTM)-39.29%

EPS (TTM)$-0.16

10-Day Avg Trading Volume10.25M

EPS Excl Extra (TTM)$-0.16

Revenue Growth (5Y)56.51%

EPS (Annual)$-0.16

ROI (Annual)-19.08%

Gross Margin (Annual)61.15%

Net Profit Margin (5Y Avg)-184.48%

Cash / Share (Quarterly)$0.60

Revenue Growth QoQ (YoY)-6.46%

ROA (Last FY)-14.97%

Revenue Growth TTM (YoY)8.36%

EBITD / Share (TTM)$-0.21

ROE (5Y Avg)-38.12%

Operating Margin (TTM)-53.50%

Cash Flow / Share (Annual)$-0.15

P/B Ratio3.03x

P/B Ratio (Quarterly)2.99x

Net Income / Employee (Annual)$-147,000

EV / Revenue (TTM)3.47x

Net Interest Coverage (TTM)-9.59x

ROA (TTM)-15.52%

EPS Incl Extra (Annual)$-0.16

Current Ratio (Annual)2.45x

Quick Ratio (Quarterly)2.10x

3-Month Avg Trading Volume10.89M

52-Week Price Return-17.46%

Revenue / Employee (TTM)$379,600

Tangible BV / Share (Quarterly)$0.53

P/S Ratio (Annual)4.37x

Asset Turnover (Annual)0.39x

52-Week High$35.50

Operating Margin (5Y Avg)-186.24%

EPS Excl Extra (Annual)$-0.16

CapEx CAGR (5Y)4.70%

Tangible BV CAGR (5Y)-11.31%

26-Week Price Return-18.40%

Quick Ratio (Annual)2.18x

13-Week Price Return-9.53%

Total Debt / Equity (Annual)0.29x

Current Ratio (Quarterly)2.40x

Enterprise Value$1.57B

Revenue / Share Growth (5Y)46.10%

Asset Turnover (TTM)0.39x

Book Value / Share Growth (5Y)-13.45%

Revenue / Employee (Annual)$385,400

Inventory Turnover (Annual)3.12x

Pretax Margin (Annual)-38.78%

Cash / Share (Annual)$0.62

3-Month Return Std Dev54.21%

Gross Margin (5Y Avg)63.56%

Net Income / Employee (TTM)$-149,200

ROE (Last FY)-24.53%

Net Interest Coverage (Annual)-9.67x

EPS Basic Excl Extra (Annual)$-0.16

Receivables Turnover (TTM)6.94x

Total Debt / Equity (Quarterly)0.32x

EPS Incl Extra (TTM)$-0.16

Receivables Turnover (Annual)4.81x

ROI (TTM)-19.13%

P/S Ratio (TTM)4.43x

Pretax Margin (5Y Avg)-184.44%

Revenue / Share (Annual)$0.42

Tangible BV / Share (Annual)$0.58

Price vs S&P 500 (52W)-17.82%

Year-to-Date Return-0.59%

5-Day Price Return-4.97%

EPS Normalized (Annual)$-0.16

ROA (5Y Avg)-29.81%

Net Profit Margin (Annual)-38.15%

Month-to-Date Return-2.44%

Cash Flow / Share (TTM)$-2.36

EBITD / Share (Annual)$-0.20

Operating Margin (Annual)-49.86%

ROI (5Y Avg)-36.20%

EPS Basic Excl Extra (TTM)$-0.16

P/TBV (Quarterly)3.40x

P/B Ratio (Annual)2.75x

Inventory Turnover (TTM)2.56x

Pretax Margin (TTM)-39.62%

Book Value / Share (Annual)$0.65

Price vs S&P 500 (13W)-19.28%

Beta1.20x

Revenue / Share (TTM)$0.41

ROE (TTM)-24.32%

52-Week Low$12.31

vGradeC

gGradeC

mGradeD

vgmGradeC

Show chart for

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

3.93

Industry Peers — Pharmaceuticals(550)

Symbol	Value Score	Growth Score	Momentum Score	Price
ZLABZai Lab Limited American Depositary Shares	C	C	D	$17.09
LLYEli Lilly & Co.	D	B	B	$1082.20
JNJJohnson & Johnson	C	C	C	$223.51
ABBVABBVIE INC.	D	C	C	$212.93
MRKMerck & Co., Inc.	C	C	C	$115.17
NVSNovartis AG	C	C	C	$145.68
AZNAstraZeneca PLC	D	B	C	$179.71
NVONovo-Nordisk A/S	B	B	C	$44.07
PFEPfizer Inc.	B	C	C	$25.63
ABTAbbott Laboratories	C	C	D	$87.78
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$34.64

About

Zai Lab is a biopharmaceutical company developing proprietary therapeutics in oncology, autoimmune disease, and infectious disease. The company's clinical pipeline is focused on targeted antibody-drug conjugates, including programs for solid tumors, small cell lung cancer, and neuroendocrine cancers. Key candidates include ZL-1218, ZL-1310, ZL-6301, and ZL-6201, addressing multiple tumor types with novel mechanisms of action.